The Precivity™ tests are innovative new blood tests intended for use in patients 55* and older with signs or symptoms of mild cognitive impairment or dementia. These tests aid healthcare providers in the detection of amyloid plaques in the brain, a pathological hallmark of Alzheimer's disease, and inform medical management and treatment decisions.
Inform brain health with accurate insights
Use our innovative blood tests to get a clear picture of Alzheimer's disease pathology.
*Precivity-ApoE™, blood test is intended for use in patients aged 18 and older.
“These tests answer a critical need for less costly and more accessible diagnostic testing in memory and dementia care.”
— Howard Fillit, M.D., Founding Executive Director and Chief Science Officer of the Alzheimer’s Drug Discovery Foundation
Recent News
Webinars
